Profound Medical (PROF) Competitors $5.98 -0.11 (-1.72%) As of 07/3/2025 03:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CBLL, BBNX, AVNS, EMBC, BVS, KIDS, RXST, BFLY, AXGN, and DCTHShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Embecta (EMBC), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), Butterfly Network (BFLY), AxoGen (AXGN), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors CeriBell Beta Bionics Avanos Medical Embecta Bioventus OrthoPediatrics RxSight Butterfly Network AxoGen Delcath Systems Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Does the media refer more to PROF or CBLL? In the previous week, Profound Medical had 1 more articles in the media than CeriBell. MarketBeat recorded 1 mentions for Profound Medical and 0 mentions for CeriBell. Profound Medical's average media sentiment score of 0.75 beat CeriBell's score of 0.00 indicating that Profound Medical is being referred to more favorably in the media. Company Overall Sentiment Profound Medical Positive CeriBell Neutral Do analysts recommend PROF or CBLL? Profound Medical currently has a consensus target price of $11.50, indicating a potential upside of 92.15%. CeriBell has a consensus target price of $32.14, indicating a potential upside of 69.84%. Given Profound Medical's higher possible upside, equities analysts clearly believe Profound Medical is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-269.35% -70.41% -57.22% CeriBell N/A N/A N/A Which has preferable earnings and valuation, PROF or CBLL? Profound Medical has higher earnings, but lower revenue than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M16.84-$27.82M-$1.22-4.91CeriBell$65.44M10.45-$40.46MN/AN/A Do institutionals & insiders have more ownership in PROF or CBLL? 47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 20.1% of CeriBell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryProfound Medical and CeriBell tied by winning 6 of the 12 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$179.57M$2.43B$5.56B$9.03BDividend YieldN/A1.67%5.22%3.99%P/E Ratio-4.919.3527.6920.25Price / Sales16.84478.02389.63163.10Price / CashN/A158.5936.8958.10Price / Book2.984.588.035.67Net Income-$27.82M$31.34M$3.18B$249.21M7 Day Performance-0.25%3.25%2.93%3.28%1 Month Performance7.45%3.46%1.72%3.95%1 Year Performance-32.75%0.77%34.39%20.98% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.6647 of 5 stars$5.99-1.7%$11.50+92.1%-32.8%$179.57M$10.68M-4.91150Negative NewsCBLLCeriBell1.9061 of 5 stars$18.73-0.9%$32.14+71.6%N/A$683.10M$65.44M0.00N/ABBNXBeta BionicsN/A$14.56-3.4%$23.44+61.0%N/A$653.38M$65.12M0.00294AVNSAvanos MedicalN/A$12.25+0.3%N/A-36.1%$564.64M$689.20M-1.462,227EMBCEmbecta4.147 of 5 stars$9.69+0.5%$19.33+99.5%-9.9%$563.39M$1.12B10.772,100BVSBioventus2.7167 of 5 stars$6.62-2.2%$14.33+116.5%+22.5%$543.79M$567.70M-10.851,200Positive NewsKIDSOrthoPediatrics3.9068 of 5 stars$21.48+0.5%$35.83+66.8%-27.1%$519M$204.73M-12.27200RXSTRxSight1.7514 of 5 stars$13.00+2.6%$37.90+191.5%-76.8%$514.87M$139.93M-19.40220News CoveragePositive NewsBFLYButterfly Network2.4662 of 5 stars$2.00+1.8%$4.00+100.5%+102.0%$484.69M$82.06M-6.88460News CoverageAnalyst ForecastAXGNAxoGen2.0301 of 5 stars$10.85+3.3%$22.20+104.6%+44.8%$478.21M$187.34M-72.33450Positive NewsHigh Trading VolumeDCTHDelcath Systems3.5125 of 5 stars$13.60+0.2%$24.00+76.5%+59.9%$472.59M$37.21M-27.2060News CoverageAnalyst Downgrade Related Companies and Tools Related Companies CBLL Competitors BBNX Competitors AVNS Competitors EMBC Competitors BVS Competitors KIDS Competitors RXST Competitors BFLY Competitors AXGN Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
